Form 8-K - Current report:
SEC Accession No. 0001213900-25-011733
Filing Date
2025-02-10
Accepted
2025-02-10 16:00:32
Documents
19
Period of Report
2025-02-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0230277-8k_inmune.htm   iXBRL 8-K 31909
2 LICENSE AGREEMENT, DATED FEBRUARY 6, 2025, BETWEEN INMUNE BIO INC. AND GREAT ORM ea023027701ex10-1_inmune.htm EX-10.1 109041
3 TERMINATION LETTER, DATED FEBRUARY 6, 2025, BETWEEN INMUNE BIO INC. AND SILICON ea023027701ex10-2_inmune.htm EX-10.2 13660
4 PRESS RELEASE, DATED FEBRUARY 10, 2025 ea023027701ex99-1_inmune.htm EX-99.1 27318
8 GRAPHIC ex10-2_001.jpg GRAPHIC 19477
9 GRAPHIC ex99-1_001.jpg GRAPHIC 1870
10 GRAPHIC ex99-1_002.jpg GRAPHIC 163469
  Complete submission text file 0001213900-25-011733.txt   650943

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE inmb-20250206.xsd EX-101.SCH 3018
6 XBRL LABEL FILE inmb-20250206_lab.xml EX-101.LAB 34240
7 XBRL PRESENTATION FILE inmb-20250206_pre.xml EX-101.PRE 22361
21 EXTRACTED XBRL INSTANCE DOCUMENT ea0230277-8k_inmune_htm.xml XML 3679
Mailing Address 225 NE MIZNER BLVD, SUITE 640 BOCA RATON FL 33432
Business Address 225 NE MIZNER BLVD, SUITE 640 BOCA RATON FL 33432 8589643720
Inmune Bio, Inc. (Filer) CIK: 0001711754 (see all company filings)

EIN.: 475205835 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38793 | Film No.: 25605646
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)